Nicola Fusco: Our article on “low-risk TNBC” has been included in Elsevier’s Breast Cancer Awareness Month article collection! 

Nicola Fusco, made the following post on LinkedIn:

“Our article on “low-risk TNBC” has been included in Elsevier’s Breast Cancer Awareness Month article collection!

This article discusses the challenges provided by Triple-Negative Breast Cancers (TNBCs) risk stratification and sheds light on their clinical and molecular characteristics.

Here’s a sneak peek into what our research entails:
Triple-negative breast cancers (TNBC) are known for their heterogeneity and challenging clinical course. However, within this group, there exists a spectrum of low-risk TNBCs with minimal metastatic potential.
These include salivary gland-type tumors, those with extensive apocrine differentiation and/or high TILs, and small-sized early-stage TNBCs.

The challenge lies in de-escalating treatment for these low-risk TNBCs due to the lack of dedicated clinical trials and cancer registries.

We address the diagnostic challenges and highlight crucial biological characteristics that underpin their favorable clinical course.

If you’re interested in learning more, you can read the full article here.

Link to the collection.”

Source: Nicola Fusco/LinkedIn

Nicola Fusco is the Director of the Division of Pathology at IEO European Institute of Oncology IRCCS. He is an Associate Professor at the Department of Oncology and Hemato-Oncology, University of Milan. He is co-founder of www.4Oncommunity.com a ticketing service and portal for oncology and molecular pathology specialists.